Electrocardiogram changes in patients with end stage renal disease on chronic haemodialysis


  • Kareem Mohsin Yousif Department of medicine, AL- Hussiania Hospital, Karbala Health Directorate, Karbala, Iraq
  • Hamid Obaid Khadhim Al Jaaed Department of medicine, Afak general Hospital, Aldiwanyia Health directorate, Aldiwanyia, Iraq




Electrocardiogram, End stag, Haemodialysis, Renal disease


Background: End stage renal disease (ESRD) is irreversible loss of renal function which is physiologically defined by a GFR of less than 15 ml / minute. ESRD is associated with a higher incidence of coronary artery disease and serious arrhythmia especially ventricular arrhythmia. The goal of study is to determine whether ESRD and haemodialysis (HD)are associated with occurrence of significant electrocardiogram (ECG) changes or not.

Methods: This is a cross-sectional study design which involved 22 patients with ESRD on regular HD in Al Sadre teaching hospital / Al Najaf. Both sexes was included in this study. All patients underwent full medical history and examination which included the following aspects: Age, Sex, Occupation, BP, HR, RBS, B.urea, S.creatinine , Serum electrolyte (Na+, K+, Cl-, Ca++), Lipid profile (Cholesterol , Triglyceride, HDL, LDL), Duration of CRF, Duration of dialysis, Social history including (smoking, alcohol) and Drug used by the patient. Resting EGC and Hotler ECG.

Results: Eighteen patients exhibited emergence of simple ectopic activity premature atrial complex (PAC) and premature ventricular complex (PVC) events and four patients exhibited (ST,T changes). Potentially lethal arrhythmias and other serious ECG changes are not detected in our patient’s sample.

Conclusion: In this study, neither ESRD nor haemodialysis were associated with development of serious ECG changes or emergence of significant arrhythmia.


Burton JO, Jefferies HJ, Selby NM, McIntyre CW. Hemodialysis-induced cardiac injury: determinants and associated outcomes. Clin J Am Soc Nephrol. 2009;4(5):914-20.

Collins AJ, Foley R, Herzog C, Chavers B, Gilbertson D, Ishani A, et al. United States Renal Data System 2007 Annual Data Report Abstract. Am J Kid Dis. 2008;51(1):A6-7.

Herzog CA, Mangrum JM, Passman R. Sudden cardiac death and dialysis patients. Semin Dial. 2008;21(4):300-7.

Genovesi S, Valsecchi MG, Rossi E, Pogliani D, Acquistapace I, De Cristofaro V, et al. Sudden death and associated factors in a historical cohort of chronic haemodialysis patients. Nephrol Dial Transplant. 2009;24(8):2529-36.

Cheung AK, Sarnak MJ, Yan G, Berkoben M, Heyka R, Kaufman A, et al. HEMO Study Group. Cardiac diseases in maintenance hemodialysis patients: results of the HEMO study. Kidney Int. 2004;65(6):2380-9.

Wanner C, Krane V, Marz W, Olschewski M, Mann JF, Ruf G, et al. German Diabetes and Dialysis Study Investigators. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med. 2005;353(3):238-48.

Herzog CA, Strief JW, Collins AJ, Gilbertson DT. Cause-specific mortality of dialysis patients after coronary revascularization: why don't dialysis patients have better survival after coronary intervention? Nephrol Dial Transplant. 2008;23(8): 2629-33.

Krishnan AV, Kiernan MC. Uremic neuropathy: clinical features and new pathophysiological insights. Muscle Nerve. 2007;35(3):273-90.

Parfrey PS, Foley RN, Harnett JD. Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant.1996;11(7):1277-85.

Mark PB, Johnston N, Groenning BA, Foster JE, Blyth KG, Martin TN, et al. Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging. Kidney Int. 2006;69(10):1839-45.

Tun A, Khan IA, Wattanasauwan N, Win MT, Hussain A, Hla TA, et al. Increased regional and transmyocardial dispersion of ventricular repolarization in end-stage renal disease. Can J Cardiol. 1999;15(1):53-6.

Morris ST, Galiatsou E, Stewart GA, Rodger RS, Jardine AG. QT dispersion before and after hemodialysis. J Am Soc Nephrol. 1999;10(1):160-3.

Wu VC, Lin LY, Wu KD. QT interval dispersion in dialysis patients. Nephrol (Carlton). 2005;10(2):109-12.

Stewart GA, Gansevoort RT, Mark PB, Rooney E, McDonagh TA, Dargie HJ, et al. Electrocardiographic abnormalities and uremic cardiomyopathy. Kidney Int. 2005;67(1):217-26.

Yetkin E, Ileri M, Tandoğan I, Boran M, Yanik A, Hisar I, et al. Increased QT interval dispersion after hemodialysis: role of peridialytic electrolyte gradients. Angiol. 2000;51(6):499-504.

Meier P, Vogt P, Blanc E. Ventricular arrhythmias and sudden cardiac death in end-stage renal disease patients on chronic hemodialysis. Nephron. 2001; 87(3):199-214.

Mohi-ud-din K, Bali HK, Banerjee S, Sakhuja V, Jha V. Silent myocardial ischemia and high-grade ventricular arrhythmias in patients on maintenance hemodialysis. Ren Fail. 2005;27(2):171-5.

Burton JO, Korsheed S, Grundy BJ, McIntyre CW. Hemodialysis-induced left ventricular dysfunction is associated with an increase in ventricular arrhythmias. Ren Fail. 2008;30(7):701-9.

Epstein AE, Dimarco JP, Ellenbogen KA, Estes NA III, Freedman RA, Gettes LS, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: executive summary. Heart Rhythm. 2008;5(6):934-55.

Sakhuja R, Keebler M, Lai TS, McLaughlin Gavin C, Thakur R, Bhatt DL. Meta-analysis of mortality in dialysis patients with an implantable cardio verterde fibrillator. Am J Cardiol. 2009;103(5):735- 7-41.

Amin MS, Fox AD, Kalahasty G, Shepard RK, Wood MA, Ellenbogen KA. Benefit of primary prevention implantable cardioverter defibrillators in the setting of chronic kidney disease: a decision model analysis. J Cardiovasc Electrophysiol. 2008; 19(12):1275-80.

Cuculich PS, Sánchez JM, Kerzner R, Greenberg SL, Sengupta J, Chen J, et al. Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death. Pacing Clin Electrophysiol. 2007;30(2):207-13.

Herzog CA, Li S, Weinhandl ED, Strief JW, Collins AJ, Gilbertson DT. Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverterde fibrillators. Kidney Int. 2005;68(2): 818-25.

Saravanan P, Freeman G, Davidson NC. Risk assessment for sudden cardiac death in dialysis patients: how relevant are conventional cardiac risk factors? Int J Cardiol. 2009. doi:10.1016/j.ijcard.2009.03.048.

Zipes DP, Wellens HJJ. Sudden cardiacdeath. Circulation. 1998;98:2334-51.

Converse Jr RL, Jacobsen TN, Toto RD, Jost CM, Cosentino F, Fouad-Tarazi F, et al. Sympathetic overactivity in patients with chronic renal failure. New England J Med. 1992 Dec 31;327(27):1912-8.

Zoccali C, Mallamaci F, Parlongo S, Cutrupi S, Benedetto FA, Tripepi G, et al. Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease. Circulation. 2002;105(11):1354-9.

Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use.Circulation.1996;93(5):1043-65.

Kleiger RE, Stein PK, Bigger JT Jr. Heart rate variability: measurement and clinical utility. Ann Noninvasive Electrocardiol. 2005;10(1):88-101.

Levin A, Singer J, Thompson CR, Ross H, Lewis M. Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention. Am J Kidney Diseases. 1996 Mar 1;27(3):347-54.

Levin A, Thompson CR, Ethier J, Carlisle EJ, Tobe S, Mendelssohn D, et al. Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. Am J Kidney Diseases. 1999 Jul 1;34(1):125-34.

Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA. 2001 Jul 25;286(4):421-6.

Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE sub-study. The lancet. 2000 Jan 22;355(9200):253-9.

Stewart GA, Gansevoort R, Mark PB, Rooney E, Mcdonagh TA, Dargie HJ, et al. Electrocardiographic abnormalities and uremic cardiomyopathy. Kidney international. 2005;67(1):217-26.

Kayatas M, Ertürk A, Muderrisoglu H, Korkmaz E, Özdemir N. Acetate hemodialysis does not increase the frequency of arrhythmia in hemodialysis patients. Artificial organs. 1998;22(9):781-4.

Abe S, Yoshizawa M, Nakanishi N, Yazawa T, Yokota K, Honda M, et al. Electrocardiographic abnormalities in patients receiving hemodialysis. Am Heart J. 1996;131(6):1137-44.




How to Cite

Yousif, K. M., & Al Jaaed, H. O. K. (2019). Electrocardiogram changes in patients with end stage renal disease on chronic haemodialysis. International Journal of Research in Medical Sciences, 7(11), 4020–4025. https://doi.org/10.18203/2320-6012.ijrms20194624



Original Research Articles